Genotypic characterization of multi-drug-resistant Mycobacterium tuberculosis isolates in Myanmar.
The number of multi-drug-resistant tuberculosis (MDR-TB) cases is rising worldwide. As a countermeasure against this situation, the implementation of rapid molecular tests to identify MDR-TB would be effective. To develop such tests, information on the frequency and distribution of mutations associating with phenotypic drug resistance in Mycobacterium tuberculosis is required in each country. During 2010, the common mutations in the rpoB, katG and inhA of 178 phenotypically MDR M. tuberculosis isolates collected by the National Tuberculosis Control Program (NTP) in Myanmar were investigated by DNA sequencing. Mutations affecting the 81-bp rifampicin (RIF) resistance-determining region (RRDR) of the rpoB were identified in 127 of 178 isolates (71.3%). Two of the most frequently affected codons were 531 and 526, with percentages of 48.3% and 14.0% respectively. For isoniazid (INH) resistance, 114 of 178 MDR-TB isolates (64.0%) had mutations in the katG in which a mutation-conferring amino acid substitution at codon 315 from Ser to Thr was the most common. Mutations in the inhA regulatory region were also detected in 20 (11.2%) isolates, with the majority at position -15. Distinct mutation rate and pattern from surrounding countries might suggest that MDR-TB has developed and spread domestically in Myanmar.
['Aye|Khin Saw|KS|', 'Nakajima|Chie|C|', 'Yamaguchi|Tomoyuki|T|', 'Win|Min Min|MM|', 'Shwe|Mu Mu|MM|', 'Win|Aye Aye|AA|', 'Lwin|Thandar|T|', 'Nyunt|Wint Wint|WW|', 'Ti|Ti|T|', 'Suzuki|Yasuhiko|Y|']
D000995:Antitubercular Agents D001426:Bacterial Proteins D012321:DNA-Directed RNA Polymerases D024901:Drug Resistance, Multiple, Bacterial D006801:Humans D008826:Microbial Sensitivity Tests D009154:Mutation D002052:Myanmar D009169:Mycobacterium tuberculosis D018088:Tuberculosis, Multidrug-Resistant
Mycobacterium tuberculosis Myanmar Resistance Rifampicin Isoniazid